As of 2025-11-04, the Relative Valuation of Sana Biotechnology Inc (SANA) is (15.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.57 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -440.5%.
The range of the Relative Valuation is (15.09) - (19.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 18.8x | 15.3x |
| Forward P/E multiples | 14.7x - 21.9x | 15.1x |
| Fair Price | (15.09) - (19.26) | (15.56) |
| Upside | -430.2% - -521.5% | -440.5% |
| Date | P/E |
| 2025-11-03 | -4.46 |
| 2025-10-31 | -4.84 |
| 2025-10-30 | -4.79 |
| 2025-10-29 | -5.25 |
| 2025-10-28 | -5.46 |
| 2025-10-27 | -5.13 |
| 2025-10-24 | -5.46 |
| 2025-10-23 | -5.46 |
| 2025-10-22 | -5.37 |
| 2025-10-21 | -5.58 |
| 2025-10-20 | -5.43 |
| 2025-10-17 | -4.91 |
| 2025-10-16 | -5.18 |
| 2025-10-15 | -5.78 |
| 2025-10-14 | -4.35 |
| 2025-10-13 | -4.24 |
| 2025-10-10 | -4.22 |
| 2025-10-09 | -4.35 |
| 2025-10-08 | -4.43 |
| 2025-10-07 | -4.02 |
| 2025-10-06 | -4.06 |
| 2025-10-03 | -3.87 |
| 2025-10-02 | -3.88 |
| 2025-10-01 | -3.61 |
| 2025-09-30 | -3.47 |
| 2025-09-29 | -3.46 |
| 2025-09-26 | -3.26 |
| 2025-09-25 | -3.31 |
| 2025-09-24 | -3.33 |
| 2025-09-23 | -3.18 |
| 2025-09-22 | -3.17 |
| 2025-09-19 | -3.02 |
| 2025-09-18 | -3.21 |
| 2025-09-17 | -2.97 |
| 2025-09-16 | -3.03 |
| 2025-09-15 | -3.16 |
| 2025-09-12 | -3.15 |
| 2025-09-11 | -3.32 |
| 2025-09-10 | -2.84 |
| 2025-09-09 | -2.95 |
| 2025-09-08 | -2.93 |
| 2025-09-05 | -2.89 |
| 2025-09-04 | -2.91 |
| 2025-09-03 | -2.92 |
| 2025-09-02 | -2.77 |
| 2025-08-29 | -2.99 |
| 2025-08-28 | -2.94 |
| 2025-08-27 | -3.29 |
| 2025-08-26 | -3.15 |
| 2025-08-25 | -3.27 |